605 related articles for article (PubMed ID: 23706948)
1. Incidence and progression of geographic atrophy: observations from a population-based cohort.
Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ
Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948
[TBL] [Abstract][Full Text] [Related]
2. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons.
Wang JJ; Fong CS; Rochtchina E; Cugati S; de Loryn T; Kaushik S; Tan JS; Arnold J; Smith W; Mitchell P
Ophthalmology; 2012 Nov; 119(11):2298-303. PubMed ID: 22959104
[TBL] [Abstract][Full Text] [Related]
3. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Progression, and Associated Risk Factors of Medium Drusen in Age-Related Macular Degeneration: Findings From the 15-Year Follow-up of an Australian Cohort.
Joachim ND; Mitchell P; Kifley A; Wang JJ
JAMA Ophthalmol; 2015 Jun; 133(6):698-705. PubMed ID: 25838066
[TBL] [Abstract][Full Text] [Related]
6. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.
Wang JJ; Foran S; Smith W; Mitchell P
Arch Ophthalmol; 2003 May; 121(5):658-63. PubMed ID: 12742843
[TBL] [Abstract][Full Text] [Related]
7. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
8. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
[TBL] [Abstract][Full Text] [Related]
9. Retinal vessel signs and 10-year incident age-related maculopathy: the Blue Mountains Eye Study.
Liew G; Kaushik S; Rochtchina E; Tan AG; Mitchell P; Wang JJ
Ophthalmology; 2006 Sep; 113(9):1481-7. PubMed ID: 16828507
[TBL] [Abstract][Full Text] [Related]
10. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.
Wang JJ; Rochtchina E; Lee AJ; Chia EM; Smith W; Cumming RG; Mitchell P
Ophthalmology; 2007 Jan; 114(1):92-8. PubMed ID: 17198852
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
12. Reticular Pseudodrusen and Their Association with Age-Related Macular Degeneration: The Melbourne Collaborative Cohort Study.
Finger RP; Chong E; McGuinness MB; Robman LD; Aung KZ; Giles G; Baird PN; Guymer RH
Ophthalmology; 2016 Mar; 123(3):599-608. PubMed ID: 26681391
[TBL] [Abstract][Full Text] [Related]
13. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
[TBL] [Abstract][Full Text] [Related]
14. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study.
Cugati S; Mitchell P; Rochtchina E; Tan AG; Smith W; Wang JJ
Ophthalmology; 2006 Nov; 113(11):2020-5. PubMed ID: 16935334
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
16. Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32.
Agrón E; Domalpally A; Cukras CA; Clemons TE; Chen Q; Swaroop A; Lu Z; Chew EY; Keenan TDL;
Ophthalmology; 2023 May; 130(5):488-500. PubMed ID: 36481221
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
[TBL] [Abstract][Full Text] [Related]
19. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
20. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
